Key result
Prehabilitation preserves expiratory pressure after cardiac surgery but fails to improve functional capacity.
Why the study?
The feasibility and efficacy of a short-term, face-to-face prehabilitation programme on cardiorespiratory functional capacity, respiratory muscle strength, frailty, psychological distress, quality of life, and hospital length of stay in patients awaiting elective cardiac surgery needed evaluation.
Does a short-term, face-to-face prehabilitation programme improve cardiorespiratory functional capacity and respiratory muscle strength compared to an incentive spirometer in patients awaiting elective cardiac surgery?
RCT (n=36)
Single-blind
2:1 allocation (24 prehabilitation vs 12 control)
Does a short-term, face-to-face prehabilitation programme improve cardiorespiratory functional capacity and respiratory muscle strength compared to an incentive spirometer in patients awaiting elective cardiac surgery?
Short-term, face-to-face prehabilitation before elective cardiac surgery is highly feasible and safe, helping to mitigate the postoperative loss of expiratory muscle strength though without improving overall functional capacity.
Answers are grounded in this paper and cite their sources.
Supports prehabilitation to protect expiratory muscle strength before cardiac surgery; extends RCT feasibility data but questions functional capacity gains.
BACKGROUND: To evaluate the feasibility and efficacy of a short-term, face-to-face prehabilitation programme in patients awaiting elective cardiac surgery, focusing on cardiorespiratory functional capacity, respiratory muscle strength, frailty, psychological distress, quality of life, and hospital length of stay. METHODS: This single-blind randomised controlled trial included patients awaiting coronary, valvular, or aortic surgery. Participants were assigned to a prehabilitation group (two sessions per week of respiratory physiotherapy, strength training, and health education) or a control group (incentive spirometer). Functional capacity (6MWT), respiratory strength (MIP/MEP), frailty (SPPB), handgrip strength, quality of life (SF-12), physical activity (IPAQ), anxiety and depression (HADS) were assessed before the intervention and one week after discharge; hospital length of stay was also assessed. RESULTS: Thirty-six patients (44% female; mean age 66.5 years) were included in the prehabilitation (n=24) and control (n=12) groups. Feasibility was high, with 92% adherence and no adverse events. Waist circumference, MIP, handgrip strength, and anxiety levels decreased significantly from pre-intervention to follow-up in both groups. In the control group, MEP also decreased significantly, while frailty increased. The only significant between-group difference was observed for MEP, with greater deterioration in the control group (Cohen's d=0.8). CONCLUSIONS: Short-term, face-to-face prehabilitation is feasible and may help mitigate the loss of expiratory muscle strength following elective cardiac surgery, although it does not improve functional capacity. Larger trials are needed to confirm its broader clinical benefits and to assess the impact of sex.
No takes yet. Share an insight, caveat, or question.
Izquierdo-García et al. (2026) conducted an RCT in Elective cardiac surgery (coronary, valvular, or aortic) (n=36). Short-term, face-to-face prehabilitation programme (respiratory physiotherapy, strength training, and health education) vs. Control group (incentive spirometer) was evaluated on Maximum expiratory pressure (MEP) and feasibility/functional capacity (6MWT) (Cohen's d 0.8). Short-term prehabilitation achieved 92% adherence and mitigated maximum expiratory pressure loss vs control after cardiac surgery, without improving functional capacity.
Synapse has enriched 10 related papers. Consider them for comparative context: